{
  "meta": {
    "data_length": 1,
    "message": "Document id doc:hc:rozlytrek retrieved successfully",
    "request_url": "http://api.moalmanac.org/documents?document_id=doc%3Ahc%3Arozlytrek",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.001785,
    "timestamp_received": "2026-09-25T00:11:50.899812+00:00Z",
    "timestamp_returned": "2026-09-25T00:11:50.901597+00:00Z",
    "trace_id": "afa2e10c-b881-4600-8a49-a27941f7ae66"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-08-02"
  },
  "data": [
    {
      "id": "doc:hc:rozlytrek",
      "type": "Document",
      "documentType": "Regulatory approval",
      "name": "Rozlytrek (entrectinib) [product monograph]. HC.",
      "title": null,
      "aliases": [],
      "description": "Hoffmann-La Roche Limited. Rozlytrek (entrectinib) [product monograph]. Health Canada website. https://pdf.hres.ca/dpd_pm/00073345.PDF. Revised November 2023. Accessed June 2025.",
      "urls": [
        "https://pdf.hres.ca/dpd_pm/00073345.PDF",
        "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98496"
      ],
      "doi": null,
      "pmid": null,
      "extensions": [
        {
          "name": "agent",
          "value": {
            "id": "agent:org:hc",
            "type": "Agent",
            "agentType": "organization",
            "name": "Health Canada",
            "description": "Regulatory agency that approves drugs for sale and use in Canada."
          },
          "description": "The organization that published this document."
        },
        {
          "name": "company",
          "value": "Hoffmann-La Roche Limited",
          "description": "The company that manufactures the cancer drug. Only applicable to market authorization documents."
        },
        {
          "name": "drug_name_brand",
          "value": "Rozlytrek",
          "description": "The brand name of the cancer drug, per this document. Only applicable to market authorization documents."
        },
        {
          "name": "drug_name_generic",
          "value": "entrectinib",
          "description": "The generic name of the cancer drug, per this document. Only applicable to market authorization documents."
        },
        {
          "name": "first_publication_date",
          "value": "2020-02-07",
          "description": "The publication date for the initial version of this document."
        },
        {
          "name": "identification_number",
          "value": null,
          "description": "Identification number used by the publishing organization."
        },
        {
          "name": "publication_date",
          "value": "2023-11-09",
          "description": "The publication date for the document."
        },
        {
          "name": "status",
          "value": "Active",
          "description": "Whether this document is Active or Deprecated within moalmanac-db."
        }
      ]
    }
  ]
}